Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs.
BACKGROUND
There have been reports of transient psychosis in women medicated for gynecologic conditions.


OBJECTIVE
The aim of this paper was to explore this literature.


METHODS
The PubMed and Google Scholar databases were searched for relevant case reports Results: The following reports were found: psychosis induced by gonadotropin-releasing hormone in the treatment of endometriosis, by clomiphene treatment for infertility, by bromocriptine treatment for milk suppression and by the withdrawal of domperidone prescribed as a galactologue as well as by the withdrawal of estrogen replacement therapy.


CONCLUSIONS
In susceptible women, psychotic symptoms can result from treatments that reduce estrogen levels, such as leuprolide acetate or clomiphene, or treatments that increase dopamine levels (bromocriptine). Psychosis can also be caused indirectly when estrogen treatment is discontinued or dopamine antagonism (e.g. domperidone) withdrawn. Estrogen-reducing and dopamine-increasing treatments used in gynecology need to be carefully monitored.
a Department of Psychiatry , University of Toronto , Toronto , ON , Canada.
Mary V
MV
Seeman
D000328:Adult; D001971:Bromocriptine / Q000009:adverse effects* / Q000627:therapeutic use; D002996:Clomiphene / Q000009:adverse effects* / Q000627:therapeutic use; D004294:Domperidone / Q000009:adverse effects* / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects* / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000175:diagnosis*
D018492:Dopamine Antagonists; D004965:Estrogen Antagonists; D002996:Clomiphene; D001971:Bromocriptine; D004294:Domperidone; D016729:Leuprolide
Bromocriptine; clomiphene; domperidone; dopamine; estrogen; leuprolide acetate